MIM
PFE icon

MTM Investment Management’s Pfizer PFE Stock Holding History

MTM Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Buy
12,819
+6
+0% +$157 0.09% 172
2026
Q1 		$360K Sell
12,813
-4
-0% -$106 0.11% 154
2025
Q4 		$319K Sell
12,817
-1,580
-11% -$39.8K 0.1% 164
2025
Q3 		$367K Buy
14,397
+31
+0.2% +$765 0.12% 153
2025
Q2 		$348K Buy
14,366
+41
+0.3% +$956 0.12% 151
2025
Q1 		$352K Buy
14,325
+45
+0.3% +$1.18K 0.14% 150
2024
Q4 		$379K Sell
14,280
-4,354
-23% -$118K 0.15% 143
2024
Q3 		$533K Buy
18,634
+87
+0.5% +$2.54K 0.21% 111
2024
Q2 		$519K Buy
18,547
+140
+0.8% +$3.85K 0.21% 106
2024
Q1 		$511K Sell
18,407
-622
-3% -$17.3K 0.21% 107
2023
Q4 		$548K Buy
19,029
+69
+0.4% +$2.09K 0.25% 99
2023
Q3 		$629K Buy
18,960
+56
+0.3% +$1.98K 0.32% 82
2023
Q2 		$693K Buy
18,904
+50
+0.3% +$1.95K 0.34% 81
2023
Q1 		$769K Sell
18,854
-6,401
-25% -$276K 0.39% 72
2022
Q4 		$1.29M Sell
25,255
-104
-0.4% -$4.99K 0.67% 43
2022
Q3 		$1.11M Buy
25,359
+5
+0% +$243 0.63% 45
2022
Q2 		$1.33M Buy
25,354
+6
+0% +$306 0.72% 39
2022
Q1 		$1.31M Sell
25,348
-9
-0% -$467 0.63% 45
2021
Q4 		$1.5M Buy
25,357
+4
+0% +$198 0.71% 40
2021
Q3 		$1.09M Sell
25,353
-8,395
-25% -$372K 0.59% 48
2021
Q2 		$1.32M Sell
33,748
-395
-1% -$15.4K 0.69% 44
2021
Q1 		$1.24M Sell
34,143
-210
-0.6% -$7.46K 0.7% 45
2020
Q4 		$1.26M Buy
+34,353
New +$1.26M 0.78% 34

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MTM Investment Management's PFE Position: Q2 2026 in Review

MTM Investment Management increased its Pfizer (PFE) stake by 0.05% in Q2 2026, buying an estimated $157 and bringing the position to 12,819 shares worth $309K. The position accounts for 0.09% of the portfolio, ranked #172.

MTM Investment Management first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.5M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MTM Investment Management held 12,819 shares of Pfizer worth $309K as of Q2 2026.
  • MTM Investment Management bought 6 Pfizer shares in Q2 2026, an estimated $157.
  • Pfizer made up 0.09% of MTM Investment Management's portfolio in Q2 2026, its #172 holding.
  • MTM Investment Management first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • MTM Investment Management's Pfizer position peaked at $1.5M in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.